Dr. Narender Kumar Thota

HOD & Consultant Hemato Oncologist & Stem Cell / BMT Bone Marrow Transplant Specialist


OP Timings :


MondayTuesdayWednesdayThursdayFridaySaturdaySunday
10:00am - 04:00pm10:00am - 04:00pm10:00am - 04:00pm10:00am - 04:00pm10:00am - 04:00pm10:00am - 04:00pmNot Available

 

Qualifications

  • Nizam's Institute of Medical Sciences, Hyderabad. D.M (Fellowship - Medical Oncology) 2009 - 2012
  • Gandhi medical college, Hyderabad, Vijayawada, NTR University of Health Sciences, A.P. M.D (Residency - Internal Medicine) 2005 - 2008
  • Kakatiya Medical College, Warangal, NTR University of Health Sciences. M.B.B.S 1996 – 2002


Special Training

Workshops/Symposiums:

  • CPR – BLS / ACLS (Workshop) American heart association March 2003
  • ACLS workshop At Yashoda Superspeciality hospital Dec 2008
  • Young Medical Oncologists Meet MOFA, Hyderabad 10-11th June, 2008
  • Advancement in Renal Cell Carcinoma Mumbai, India 31st July – 1st Aug. 2010
  • Statistics for Health Researchers ( Online course) University of Oxford, London, U.K. 17 May - 23 July 2010

Conferences

  • 42nd Annual Congress, SIOP at Boston, USA International society of pediatric oncology, Boston, USA 21 – 24, Oct, 2010
  • Annual Conference of ASCO at Chicago, USA American Society of Clinical Oncology, USA June 3 – 7, 2011
  • Lymphomas and leukemias 2012, Mumbai, India 6-8 Jan, 2012
  • ISMPO Meet 2012 Vishakhapatnam, Andhra Pradesh , India February 2012
  • Global oncology summit (March 2013) Hyderabad, India 28-31 March, 2013
  • 2nd ISHBT EHA tutorial on myeloid malignancies and multiple myeloma Mumbai, India 29th to 31st January 2016.


Experience

  • Worked as Full time consultant - Medical oncologist and hemato-oncologist at Krishna Institute of Medical sciences, Secunderabad. Aug 2012 Till present
  • DM Resident (fellowship) in Medical Oncology, Nizam’s Institute of Medical sciences, Hyderabad. Aug. 2009 July. 2012
  • Observer-ship in BMT and Hematology and oncology unit at case western university, Cleveland, Ohio, USA.( Exchange program) 26 Oct 2010 14 Nov 2010
  • Registrar in Department of Medicine, Yashoda Superspeciality hospital, Secunderabad Sep. 2008 April. 2009
  • Post graduation in (Residency) M.D (Internal Medicine) Gandhi Medical Secunderabad. 22 Aug 2005 21 Aug 2008
  • Medical officer in medicine & cardiology, care hospital, Secunderabad, Oct 2002 Jan 2005 Internship - Mahatma Gandhi memorial hospital, Warangal. June 2001 May 2002


Publications


Plasma Cell Leukaemia Masquerading As Hairy Cell Leukaemia- A Case Report

Published online 22 January 2013. Indian Journal of Haematology and Blood Transfusion (Indian J Hematol Blood Transfusion DOI 10.1007/s12288-013-0228-5)

Thota Narender Kumar, Kalpathi Krishnamani, Linga Vijay Gandhi, Gundeti Sadashivudu, Digumarti Raghunadharao.

Imatinib Mesylate (IM) As First Line Therapy In Patients With Chronic Myeloid Leukemia (CML) In Accelerated Phase (AP) And Blast Phase (BC): A Retrospective Analysis

Indian J Cancer 2014; 51:5-9.

Narender Kumar Thota, S Gundeti, Pragnya Coca, Vijay Gandhi. L, Jayanthi Sri rambhatla, RadhikaP, Raghunadharao, Srinivas B͙* Dept. of Medical Oncology and *Pathology, Nizam’s Institute of Medical Sciences, Hyderabad, India

T – CLL/T – PLL: Experience with single agent Bendamustine Case report - Indian Journal of Cancer. Published on April – June 2015.

Narender Kumar Thota*, Sadashivudu Gundeti*, Pragnya coca, Vijay Gandhi Linga*, bhTara Roshni Paul# Raghunadharao Digumarti*

*Departments of Medical Oncology, #Department of Pathology*, Nizam’s Institute of Medical Sciences, Hyderabad, India.

Therapy Related Acute Promyelocytic Leukemia Following Etoposide Based Chemotherapy In Non–Seminomatous Germ Cell Tumor.

Published - J Postgrad Med 2014; 60:84-5. - Case snippet

Narender Kumar Thota*, Vijay Gandhi Linga*, Krishna mani*, Sadashivudu Gundeti*, Raghunadharao Digumarti* *Departments of Medical Oncology, #Department of Pathology*, Nizam’s Institute of Medical Sciences, Hyderabad, India

Para-saggital hemangiopericytoma with late presentation of liver metastases- A case report and review of literature:-

Published - South Asian journal of cancer (July- September 2013) as letters to editor, Kalpathi Krishnamani, Thota Narender Kumar, Linga Vijay Gandhi, Gundeti Sadashivudu, Digumarti Raghunadharao, Ashwani Tandon1.

Diagnostic Dilemma Of Cardiac Synovial Sarcoma - Primary Or Secondary:- Published - Journal of Indian College of Cardiology (13 May 2013) Kalpathi Krishnamani, Linga Vijay Gandhi, Thota Narender Kumar 1, Gundeti Sadashivudu, Digumarti Raghunadharao, Rama Kumari N2.

Primary Ewing’s Sarcoma of the Cranium- Case Series and Review of Literature:-Journal of Cancer Research and Therapeutics, 2014; 10:377-80.

Kalpathi Krishnamani *, Thota Narender Kumar*, Linga Vijay Gandhi*, Digumarti Raghunadharao*, Gundeti Sadashivudu*, Uppin Megha #, C. Sundaram #.

*Departments of Medical Oncology, #Department of Pathology*, Nizam’s Institute of Medical Sciences, Hyderabad, India

Bortezomib in Newly diagnosed patients with Multiple Myeloma: a retrospective analysis from a tertiary care centre in India"

Accepted for publication in Indian Journal of Cancer. The ref no: IJC_186_12

Coca Pragnya, Thota Narender Kumar, Gundeti Sadashivudu, Linga Vijay Gandhi, Srinivas Lakshmi, Digumarti Raghunadharao, Department of Medical Oncology, Nizam’s Institute of Medical Sciences, Hyderabad.

Abstracts

The Frequency Of Thiopurine Methyl Transferase Polymorphisms In Children’s With Acute Lymphoblastic Leukemia

Granted a Travelling Grant for SIOP 2010, Boston, USA

Abstract number: 681. Published in the abstract book of the SIOP.

Narender Kumar Thota*, Vijay Gandhi Linga*, Pragnya coca*, Sadashivudu Gundeti*, Tara Roshni Paul# Raghunadharao Digumarti*

CHOP chemotherapy plus rituximab compared with CHOP alone in patients with diffuse large B-cell lymphoma, from Indian subcontinent

Published as abstract in J Clin Oncol 30, 2012 (suppl; abstr e18545)

Vijay Gandhi Linga, Raghunadharao Digumarti, Rahul Narayan Maddi, Vamshi Krishna Reddy Goteke, Sadashivudu Gundeti, Narender Kumar Thota, Pragnya Coca; Department of Medical Oncology, Hyderabad, India; Nizam's Institute of Medical Sciences, Hyderabad, India

Weight loss of more than ten per cent and radiographic findings are the most important predictive factor for suspecting tuberculosis in patients with multiple myeloma post autologous transplant

G Linga, S Gundeti, Narender kumar Thota, P Coca, R Digumarti BONE MARROW TRANSPLANTATION 47, S337-S337

An anthropometric study in children with chronic myeloid leukemia on imatinib

VKR Goteke, RN Maddi, NK Thota, P Coca, B Nagalla, VG Linga, S Gundeti,

JOURNAL OF CLINICAL ONCOLOGY 30 (15)

ROSAI-DORFMAN'S DISEASE (RDD) PRESENTING AS AN ISOLATED INTRASPINAL MASS: A CASE REPORT AND REVIEW OF LITERATURE FROM THE INDIAN SUBCONTINENT

Coca, Pragnya, Narender Kumar Thota, Vijay Gandhi Linga, Sadashivudu Gundeti, Raghunadharao Digumarti, and S. V. N. Anuradha

PEDIATRIC BLOOD & CANCER 60 (9), E74-E74

Oral presentations – National

Adult Acute Promyelocytic Leukemia – Retrospective Analysis- awarded 2nd prize.

Presented as ORAL presentation at ISMPO VIZAG Meet 2012 in February 2012

Thota Narender Kumar, Gundeti sada shivudu, Coca Pragnya, Linga Vijay Gandhi, Digumarti Raghunadharao. Department of Medical Oncology, Nizam’s Institute of medical sciences, Punjagutta, Hyderabad, India.

“ Effects Of Imatinib Therapy On Serum Calcium, Phosphate And Magnesium Levels And Correlation With Musculo-Skeletal Symptoms In Chronic Myeloid Leukemia Patients”

Presented at the ISMPO VIZAG Meet 2012 in February 2012

Coca Pragnya, Thota Narender Kumar, Gundeti Sadashivudu, Linga Vijay Gandhi, Srinivas Lakshmi, Digumarti Raghunadharao, Department of Medical Oncology, Nizam’s Institute of Medical Sciences, Hyderabad

Imatinib drug level monitoring in chronic phase chronic myeloid leukemia patients after 6 months of therapy. Radhika P, Narender Kumar Thota, S Gundeti, Pragnya Coca, Vijay Gandhi. L, Jayanthi Sri rambhatla,, Raghunadharao Digumarti, Srinivas B͙* Dept. of Medical Oncology and *Pathology, Nizam’sInstitute of Medical Sciences, Hyderabad, India

Outcome of Patients on First Line Pemetrexed Doublet in Advanced Stage Adenocarcinoma of Lung Rahul Narayan Maddi, Vamshi Krishna Reddy G, Pragnya Coca, Narender Kumar Thota, Radhika P, Jayanthi S, Vijay Gandhi Linga, Sadashivudu G, Lakshmi S, Raghunadharao Digumarti

International - Poster presentation

Imatinib Mesylate (IM) As First Line Therapy In Patients With Chronic Myeloid Leukemia (CML) In Accelerated Phase (AP) And Blast Phase (BC): A Retrospective Analysis

Presented as poster at ASCO, Chicago – USA, June 2011

Selected as one of the 4 best papers from India for ASCO, USA, June 2011

Narender Kumar Thota, S Gundeti, Pragnya Coca, Vijay Gandhi. L, Jayanthi Sri rambhatla, Radhika P, Raghunadharao Digumarti, Srinivas B͙* Dept. of Medical Oncology and *Pathology, Nizam’s Institute of Medical Sciences, Hyderabad, India

An anthropometric study in children with chronic myeloid leukemia on imatinib.

Presented as poster at ASCO, Chicago, USA. June 1-5, 2012

Vamshi Krishna Reddy Goteke, Rahul Narayan Maddi, Narender Kumar Thota, Pragnya Coca, Balakrishna Nagalla, Vijay Gandhi Linga, Sadashivudu Gundeti, Raghunadharao Digumarti; Nizam's Institute of Medical Sciences, Hyderabad, India; Department of Medical Oncology, Hyderabad, India; National Institute of Nutrition, Hyderabad, India

Rosai-Dorfman’s Disease Presenting As An Isolated Intraspinal Mass: A Case Report And Review Of Literature From The Indian Subcontinent

Selected as poster at 28th Annual Meeting of the Histiocyte Society - London, UK October 8&9 2012 Pragnya Coca, Narender Kumar Thota, Vijay Gandhi Linga, Sadashivudu Gundeti, Raghunadharao Digumarti, SVN Anuradha

Initial Experience of Autologous Peripheral Blood Stem Cell Transplant – A University Hospital Experience

Presented as poster at 17 Asia- pacific bone marrow transplant, Hyderabad Oct 26-28, 2012

Vijay Gandhi Linga, Krishna Mani Iyer, Rajesh Kota, Muralidhar Gullipalli, Rahul Narayan, Maddi, Gotike Vamshi Krishna Reddy, Thota Narender Kumar, Coca Pragnya, Gundeti Sadashivudu, Maddali Lakshmi Srinivas, Digumarti Raghunadharao

Dept of Medical Oncology, Nizams Institute of Medical Sciences, Hyderabad, India. 500082

Posters – National

Primary cardiac synovial sarcoma presenting as multiple subcutaneous swellings – case report Presented at the Indian Cancer Congress- February 2011, Bhubaneshwar.

Narender Kumar Thota, Pragnya Coca, Jayanthi Srirambhatla, Radhika.P, VamshikrishnaG, Rahulnarayan.M, Vijay Gandhi Linga, SadashivuluGundeti, LakshmiM, RaghunadharaoDigumarti, DEPARTMENT OF MEDICAL ONCOLOGY, Nizam’sInstitute of Medical Sciences, Hyderabad, India

Retrospective Analysis Of Prognostic Factors And Outcomes In Small Cell Lung Cancer Presented as poster at vizag – ISMPO -2012

Thota Narender Kumar, Gundeti Sada shivudu, Coca Pragnya, Linga Vijay Gandhi, Digumarti Raghunadharao, Department of medical oncology, Nizam’s institute of Medical sciences, Hyderabad

Pediatric Acute Promyelocytic Leukemia – Retrospective Analysis Presented as poster at Mumbai LYMPHOMAS AND LEUKEMIAS 2012, 6-8 January, 2012 Thota Narender Kumar, Linga vijay Gandhi, Coca pragnya, Gundeti sada shivudu, Lakshmi srinivas M, Digumarti Raghunadharao

Department of Medical Oncology, Nizam’s Institute of medical sciences, Punjagutta, Hyderabad, India

Plasma Cell Leukaemia Masquerading As Hairy Cell Leukemia – Case Report

Presented as posters at Mumbai LYMPHOMAS AND LEUKEMIAS 2012, 6-8 January, 2012

Thota Narender Kumar, Linga Vijay Gandhi, Coca Pragnya, Gundeti sada shivudu, Lakshmi srinivas M, Digumarti Raghunadharao

Department of Medical Oncology, Nizam’s Institute of medical sciences, Punjagutta, Hyderabad, India

Imatinib Mesylate As Front Line Agent In Pediatric Chronic Myeloid Leukemia Accelerated Phase and Blast crisis Patients – Retrospective Analysis

Presented as posters at Mumbai LYMPHOMAS AND LEUKEMIAS 2012, 6-8 January, 2012 Thota Narender Kumar, Coca Pragnya, Maddi Rahul Narayan, GVK Reddy, Linga Vijay Gandhi, Gundeti Sadashivudu, Roshni Paul#, M.Lakshmi Srinivas, Digumarti Raghunadharao Department of Medical Oncology, #Depart of pathology, Nizam’s Institute of Medical Sciences, Hyderabad, India.


Awards And Honors

Awarded 2nd Prize.

Adult Acute Promyelocytic Leukemia – Retrospective Analysis. Presented as ORAL presentation at ISMPO VIZAG Meet 2012 in February 2012 Thota Narender Kumar, Gundeti Sada Shivudu, Coca Pragnya, Linga Vijay Gandhi, Digumarti Raghunadharao. Department of Medical Oncology, Nizam’s Institute of medical sciences, Punjagutta, Hyderabad, India.

Judged as one of the best poster from India for ASCO, Chicago – USA, June 2011

Imatinib Mesylate (IM) As First Line Therapy In Patients With Chronic Myeloid Leukemia (CML) In Accelerated Phase (AP) And Blast Phase (BC): A Retrospective Analysis Narender Kumar Thota, S Gundeti, Pragnya Coca, Vijay Gandhi. L, Jayanthi Sri rambhatla, Radhika P, Raghunadharao Digumarti, Srinivas B͙* Dept. of Medical Oncology and *Pathology, Nizam’s Institute of Medical Sciences, Hyderabad, India


Other

Training during Medical oncology fellowship:

  • Management of various solid and haematological malignancies in adult and pediatric patients. Well-versed with various frontline protocols like
  • BFM 90, MCP 841 & Paediatric A.L.L. protocol
  • BFM 87 for paediatric A.M.L. and “7+3”/DAT protocols for adult A.M.L.
  • ABVD, COPP, BFM 86, hyper CVAD, CODOX-M/IVAC, FLAG, FLAG-Ida, DHAP, ASHAP, ESHAP, R-ICE protocols for relapsed leukemias and lymphomas
  • High dose Ifosfamide / Cyclophosphamide and High dose Methotrexate based regimens for sarcomas (soft tissue and bone).
  • BEAM, BuCy, HD Melphalan for stem cell transplants
  • Conventional protocols like FAC, CMF, AT, ACT for breast cancer; Platinum-based regimens for lung, testicular and ovarian cancers; P+F, TIP for head and neck cancers; FOLFOX, FOLFIRI, CAPOX, CAPIRI etc. for colorectal cancers; concurrent chemo-radiation protocols for head and neck, oesophageal and anal canal/rectal cancers
  • Experience with newer molecules like Rituximab, Cetuximab, Herceptin, Bevacizumab, Velcade, Gefitinib etc.
  • Maintenance of chemo ports, central catheters, PICCs, Omaya reservoirs etc.

Bone marrow transplant fellowship training in

  • Allogenic transplant - Siblings, matched unrelated, haploidentical and cord blood transplant High dose chemotherapy/ Auto BMT and management of associated toxicities
  • Lumbar punctures and intrathecal administration of chemotherapeutic agents
  • Ascitic fluid and pleural fluid tappings
  • FNAC from breast masses, lymph nodes, lung masses, subcutaneous nodules, skin lesions etc.

As Faculty

  • Stem cell conference – KIMS
  • Guest lecture on BMT – chalamada ananda rao karimnagar – 30.08.15
  • Update on current management of chronic leukemias – 5-6.09.15 KIMS cancer summit , Hyderabad
  • Resurrecting PARP inhibitors in Advanced breast cancer – 20.02.16 , Update on ABC 3 hyderabad, Taj Vivanta

Fellow ship, precetorships and travel grants

  • Travel grant to attend SIOP conference. SIOP 2010 BOSTON USA
  • Fellowship in Bone marrow transplant unit at CITY OF HOPE national medical center, Los Angeles, California 1 Nov 2013 - 28 Feb 2014 Los Angeles California, USA
  • Travel Grant and ESMO Preceptorship on Colorectal Cancer 27-28 March 2015 Singapore

Patient videos loading...
Doctor videos loading...
News & Events loading...

Health Blogs

Doctors talk loading...

If you are looking out for the Best Medical Oncologist In Hyderabad , then your search ends with Dr. T. Narender Kumar. Doctor T Narender Kumar is a consultant, medical & Hemato Oncologist, and BMT physician at the Krishna Institute of Medical Sciences. Having completed his M.B.B.S from Kakatiya Medical College, Warangal, NTR University of Health Sciences in 1996 – 2002, he further pursued an A.P M.D (Residency- Internal Medicine) from Gandhi medical college, Hyderabad, Vijayawada, NTR University of Health Sciences in 2005 – 2008 and D.M (Fellowship- Medical Oncology) from Nizam’s Institute of Medical Sciences, Hyderabad in 2005-2008.


Hence, with a host of technical qualifications and skills, Dr. T. Narender Kumar is the top Hemato Oncology Doctor In Hyderabad. Besides the technical qualifications, he also has adept soft skills he gained while his tenure and experience in different hospitals. Presently, Dr. T. Narender Kumar works as a full-time consultant and medical & Hemato Oncologist at the Krishna Institute of Medical Sciences, Secunderabad since August 2012. Before this, he also gained experience as an observer-ship in BMT and haematology and oncology Unit at Case Western University, Cleveland, Ohio USA from 26th Oct, 2010 to 14th Nov, 2010. No doubt why Dr. Kumar has performed umpteen successful treatments in the past and helped the cancer patients with this top-notch skillset.


Equipped with cutting-edge technology and first-rate architecture, Dr. Kumar leaves no stone unturned to fabricate the best-customized treatment plans for his patients. He educates the cancer patients and their families about cancer and includes them in each step of the procedure so that they can make informed decisions. With a patient-friendly approach, you can substantiate the reliability of Dr. Kumar from the fact that he has extensive qualifications, training & experience in the field. Still wondering why he is touted as the Best Medical Oncologist In Hyderabad? Have a glance at the training he received during medical oncology fellowship-


1. Management of various solid and haematological malignancies in adult and pediatric patients. Well-versed with various frontline protocols like

2. BFM 90, MCP 841 & Paediatric A.L.L. protocol

3. BFM 87 for paediatric A.M.L. and “7+3”/DAT protocols for adult A.M.L.

4. ABVD, COPP, BFM 86, hyper CVAD, CODOX-M/IVAC, FLAG, FLAG-Ida, DHAP, ASHAP, ESHAP, R-ICE protocols for relapsed leukemias and lymphomas

5. High dose Ifosfamide / Cyclophosphamide and High dose Methotrexate based regimens for sarcomas (soft tissue and bone).


He also received Bone marrow transplant fellowship training in-

1. Allogenic transplant - Siblings, matched unrelated, haploidentical and cord blood transplant High dose chemotherapy/ Auto BMT and management of associated toxicities

2. Lumbar punctures and intrathecal administration of chemotherapeutic agents

3. Ascitic fluid and pleural fluid tappings

4. FNAC from breast masses, lymph nodes, lung masses, subcutaneous nodules, skin lesions etc.


So, being the top Cancer Specialist In Hyderabad, Dr. Kumar was judged as one of the best posters from India for ASCO, Chicago – USA, June 2011 and even awarded 2nd Prize in Adult Acute Promyelocytic Leukemia – Retrospective Analysis. Presented as ORAL presentation at ISMPO VIZAG Meet 2012 in February 2012.


What’s even great is that Dr. T. Narender Kumar provides comprehensive services to cancer patients right from your first appointment to post-follow-up consultations. He makes sure that you heal quickly and that the risks and complications are reduced. With umpteen skills and proficiencies, you can seek an appointment from this Top Bone Marrow Transplantation Surgeon in Hyderabad at affordable rates.

BOOK AN APPOINTMENT

FIND A DOCTOR

Footer Loading...